Biodelivery Sciences International reported $15.62M in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acelrx Pharmaceuticals ACRX:US $ -8633000 1.38M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Agile Therapeutics AGRX:US -15774000 877K
Biocryst Pharmaceuticals BCRX:US $ -44.58M 15M
Biodelivery Sciences International BDSI:US $ 15.62M 4.25M
Cara Therapeutics CARA:US $ -1124000 29.75M
Cti Biopharma CTIC:US $ -23.38M 3.88M
Daiichi Sankyo 4568:JP Y 38973M 6796M
Depomed DEPO:US $ 5.93M 17.93M
Endo International Ordinary Shares ENDP:US $ 89.16M 53.95M
JAZZ PHA JAZZ:US $ 28.37M 97.96M
Johnson & Johnson JNJ:US $ 3849M 2813M
Knight Therapeutics Inc GUD:CN C$ 4.11M 3.92M
Lannett LCI:US $ -8.15M 25.68M
Mannkind MNKD:US $ -1.66M 30.74M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Pacira Pharmaceuticals PCRX:US $ 31.43M 3.41M
Pfizer PFE:US $ 7647M 1733M
Redhill Biopharma RDHL:US $ -24.89M 6.73M
Revance Therapeutics RVNC:US $ -72723000 2.39M
Teva Pharmaceutical TEVA:IT 623M 41M